HTRA2 and early-onset autosomal dominant Alzheimer disease: In accordance, dysfunction of HTRA2 protein activity is also associated with other neurodegenerative diseases, such as Parkinson’s or Alzheimer’s disease and represents an interesting target in cancer therapy [53,61].